ArticleJournal of immunology (Baltimore, Md. : 1950)2025
Dysregulation of complement components associated with inflammation and coagulation in virally suppressed people living with HIV.
Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- P-Selectin and Platelet-Monocyte Interaction in Inflammation: Mechanisms, Hypothesis, and Open Questions.Journal of inflammation research · 2026Review
- ADAMTS13 as a thromboinflammatory brake at the vascular-immune interface: from viral immunothrombosis to the tumor microenvironment.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Although the interplay between the complement system, platelets, and neutrophils has been considered a major contributor to inflammation and thrombogenicity, little attention has been directed toward understanding their roles in people living with human immunodeficiency virus (PLWH). We quantified and compared expression levels of complement components (C2, C3a, C5a, C9), markers for coagulation (vWF-A2, ADAMTS13, tissue factor (TF), protein C, fibrinogen), and neutrophil activation (MPO, MMP-9) in plasma between virally suppressed PLWH (n = 40) and people living without HIV (PLWoH; n = 39). Platelet and activated platelet (CD62P+ cells) counts in the plasma samples were examined by flow cytometry analysis. To determine whether PLWH's plasma promotes neutrophil extracellular traps (NETs) and whether C2 and C5a levels correlate with NET formation, an ex vivo NET assay was performed. PLWH showed significantly altered C2 and C5a levels in plasma that correlated strongly with protein C and MPO. C2 also showed a positive correlation with proinflammatory markers (SSA, SAP, IL-1β, and VEGF). Furthermore, HIV status was a significant predictor of C2 and C5a levels. CD62P expression on platelets was significantly increased in PLWH. In addition, treatment of healthy neutrophils with PLWH's plasmapromoted NET formation, and this effect was inhibited by C5aR antibody treatment and platelet removal. These data suggest that activated platelets and soluble factors, such as higher C5a levels, contribute to NET formation in PLWH. Our findings provide evidence of complement dysregulation associated with inflammation and coagulation in PLWH. Altered soluble factors and platelet activation promote NET formation, potentially driving age-related non-AIDS comorbidities (NACMs).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.